Erik Leidermark – Activity measurements and long-term risks with alpha-emitter astatine-211 for targeted alpha therapy
Health and medicine
Thesis for the degree of Doctor of Medicine at Sahlgrenska Academy, Institute of Clinical Sciences, in the research area of medical radiation sciences
Dissertation